Medication info
Tamofrex Tablets 20 mg (Tamoxifen Citrate)

Tamofrex Tablets 20 mg (Tamoxifen Citrate)

Prescription medicationTabletOral
Ingredient · strength
Tamoxifen Citrate›30.34mg / 1 tablet
Manufacturer / importer
TEVA-HANDOK PHARMA CO., LTD.
Appearance
White tablets
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 199403106 · Notified 1994.09.03 · Insurance code 626900290

Summary

Main use
Treatment of breast cancer
Who takes it
Adults
Adult dose
Administer 20~40 mg of tamoxifen per day orally in 2 divided doses (morning and evening) in adults. Adjust the dose according to symptoms.

Ingredients

Importer
TEVA-HANDOK PHARMA CO., LTD.

Efficacy & effects

Treatment of breast cancer

  • Breast cancer
View approved original text

This medication is used for the treatment of breast cancer.

How to take

Adult dose

Administer 20~40 mg of tamoxifen per day orally in 2 divided doses (morning and evening) in adults. Adjust the dose according to symptoms.

Precautions

This medication should not be used by women who are pregnant or may become pregnant. Additionally, individuals who are allergic to this medication or any of its components should not take it. It should also not be administered to patients with certain genetic lactose intolerance disorders. This medication should be used with caution in patients with decreased blood cell counts. When taking this medication, common side effects such as nausea, vaginal bleeding, skin rash, flushing, and fatigue may occur. Additionally, various side effects including blood-related abnormalities, eye conditions, immune reactions, muscle pain, headaches, dizziness, hair loss, vomiting, diarrhea, and liver function abnormalities have been reported. In the event of severe side effects, the dosage may need to be reduced or discontinued. Pregnancy should be avoided during the course of this medication, and women of childbearing age should use non-hormonal contraception. If there is a plan for pregnancy during or within 2 months after treatment, the risks to the fetus must be carefully considered. This medication may cause abnormalities related to the endometrium, so immediate examination is required in case of abnormal vaginal bleeding or gynecological symptoms. Increased risk of thrombosis may occur, so patients with a history of thrombosis or risk factors should be closely monitored. This medication can interact with certain drugs, so it is essential to consult with a doctor or pharmacist if taking other medications. Fatigue may occur while driving or operating machinery, so caution is needed. Women who are pregnant or breastfeeding should avoid using this medication, and if it must be taken, breastfeeding should be discontinued. Safety in children has not been established, so its use is not recommended. In cases of overdose, there is no specific antidote, so symptomatic treatment is important. This medication should be kept out of the reach of children and should not be stored in other containers.

Side effects

  • Nausea
  • fluid retention
  • vaginal bleeding
  • vaginal discharge
  • skin rash
  • flushing
  • fatigue
  • anemia
  • cataract
  • retinopathy
Show 72 more
  • hypersensitivity reaction
  • increased triglycerides
  • leg cramps
  • myalgia
  • uterine fibroids
  • ischemic cerebrovascular disease
  • headache
  • dizziness
  • sensory disturbances
  • vulvar itching
  • changes in the endometrium
  • hair loss
  • vomiting
  • diarrhea
  • constipation
  • changes in liver enzyme levels
  • fatty liver
  • thrombogenic response
  • thrombocytopenia
  • leukopenia
  • visual disturbances
  • pancreatitis
  • hypercalcemia
  • endometrial cancer
  • interstitial pneumonia
  • cirrhosis
  • neutropenia
  • agranulocytosis
  • corneal changes
  • optic neuropathy
  • uterine sarcoma
  • tumor flare
  • optic neuritis
  • hepatitis
  • cholestasis
  • liver failure
  • hepatocellular damage
  • liver necrosis
  • angioedema
  • Stevens-Johnson syndrome
  • cutaneous vasculitis
  • vesicular pemphigoid
  • erythema multiforme
  • endometriosis
  • cystic ovarian swelling
  • vaginal polyps
  • lupus erythematosus
  • porphyria cutanea tarda
  • radiation recall
  • insomnia
  • depressive state
  • loss of appetite
  • abdominal pain
  • deep vein thrombosis
  • cerebral thrombosis
  • lower extremity thrombophlebitis
  • phlebitis
  • amenorrhea
  • menstrual irregularities
  • uterine myomas
  • ovarian cysts
  • ovarian cysts
  • sweating
  • retinal atrophy
  • optic atrophy
  • decreased vision
  • blurriness
  • weight gain
  • edema
  • bone pain
  • malaise
  • frequent urination

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it should be kept at room temperature, avoiding extremes of heat or cold.

Appearance and packaging

Appearance

White tablets

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.